January 7, 2026 · Form 4 insider transaction
Tatsis Ourania sold 4,500 shares of Vertex Pharmaceuticals Incorporated at $474.99 per share, a transaction worth $2.14M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.